Penghua SSE STAR Biology and Medicine ETF (SHA:588250)

Assets	n/a
Expense Ratio	n/a
PE Ratio	52.87
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a
1-Year Return	-17.45%

Volume	8,877,400
Open	1.051
Previous Close	1.050
Day's Range	1.040 - 1.071
52-Week Low	0.904
52-Week High	1.299
Beta	n/a
Holdings	61
Inception Date	Mar 12, 2025

About 588250

588250.SS was created on 2025-03-12 by Penghua. The fund's investment portfolio concentrates primarily on health care equity.

• Asset Class: Equity
• Category: Health Care
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 588250
• Provider: Penghua
• Index Tracked: Shanghai Stock Exchange Science and Technology Innovation Board Composite Index - CNY - Benchmark TR Net

Performance

588250 had a total return of -17.45% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.97%.

Top 10 Holdings

51.48% of assets

Name	Symbol	Weight
Shanghai United Imaging Healthcare Co., Ltd.	688271	8.01%
Shanghai Allist Pharmaceuticals Co., Ltd.	688578	6.38%
BeOne Medicines AG	688235	6.33%
iRay Group	688301	5.56%
Sichuan Biokin Pharmaceutical Co.,Ltd.	688506	5.23%
RemeGen Co., Ltd.	688331	5.01%
Suzhou Zelgen Biopharmaceuticals Co., Ltd.	688266	4.67%
Shanghai Junshi Biosciences Co., Ltd.	688180	3.93%
APT Medical Inc.	688617	3.32%
Shanghai Haoyuan Chemexpress Co., Ltd.	688131	3.04%

Data Sources: S&P Global Market Intelligence and Finnhub

Historical data is provided by S&P Global Market Intelligence. Several fund data points are also provided by Finnhub.

Last checked:

Sep 23, 2026

Data Sources Report a data error